Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1968 1
1975 1
1978 1
1980 2
1981 1
1982 1
1984 3
1985 1
1986 4
1988 2
1989 4
1990 5
1991 3
1992 2
1993 1
1994 3
1996 3
1997 3
1998 6
1999 10
2000 3
2001 7
2002 13
2003 11
2004 6
2005 4
2006 8
2007 9
2008 17
2009 15
2010 13
2011 8
2012 15
2013 9
2014 9
2015 9
2016 12
2017 9
2018 11
2019 10
2020 12
2021 11
2022 11
2023 14
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Results by year

Filters applied: . Clear all
Page 1
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Orkin C, Schapiro JM, Perno CF, Kuritzkes DR, Patel P, DeMoor R, Dorey D, Wang Y, Han K, Van Eygen V, Crauwels H, Ford SL, Latham CL, St Clair M, Polli JW, Vanveggel S, Vandermeulen K, D'Amico R, Garges HP, Zolopa A, Spreen WR, van Wyk J, Cutrell AG. Orkin C, et al. Clin Infect Dis. 2023 Nov 17;77(10):1423-1431. doi: 10.1093/cid/ciad370. Clin Infect Dis. 2023. PMID: 37340869 Free PMC article.

The presence of RPV resistance-associated mutations, human immunodeficiency virus-1 subtype A6/A1, and body mass index 30 kg/m2 were associated with an increased risk of CVF (P < .05 adjusted incidence rate ratio), with participants with 2 of these baseline factors havi

…
The presence of RPV resistance-associated mutations, human immunodeficiency virus-1 subtype A6/A1, and body mass index 30 kg/m2 were associa …
Quantized Majorana conductance.
Zhang H, Liu CX, Gazibegovic S, Xu D, Logan JA, Wang G, van Loo N, Bommer JDS, de Moor MWA, Car D, Op Het Veld RLM, van Veldhoven PJ, Koelling S, Verheijen MA, Pendharkar M, Pennachio DJ, Shojaei B, Lee JS, Palmstrøm CJ, Bakkers EPAM, Sarma SD, Kouwenhoven LP. Zhang H, et al. Among authors: de moor mwa. Nature. 2018 Apr 5;556(7699):74-79. doi: 10.1038/nature26142. Epub 2018 Mar 28. Nature. 2018. Retraction in: Nature. 2021 Mar;591(7851):E30. doi: 10.1038/s41586-021-03373-x PMID: 29590094 Retracted.
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
Fox RJ, Cree BAC, de Sèze J, Gold R, Hartung HP, Jeffery D, Kappos L, Montalban X, Weinstock-Guttman B, Singh CM, Altincatal A, Belviso N, Avila RL, Ho PR, Su R, Engle R, Sangurdekar D, de Moor C, Fisher E, Kieseier BC, Rudick RA. Fox RJ, et al. Among authors: de moor c. Neurology. 2024 May 14;102(9):e209357. doi: 10.1212/WNL.0000000000209357. Epub 2024 Apr 22. Neurology. 2024. PMID: 38648580 Free PMC article. Clinical Trial.
Participants with Gd+ lesions were younger (37.7 vs 43.1, p = 0.001) and had lower Expanded Disability Status Scale scores at baseline (2.7 vs 3.4, p = 0.017) than participants without Gd+ lesions. sNfL levels increased in participants with Gd+ lesions (n = 65) comp …
Participants with Gd+ lesions were younger (37.7 vs 43.1, p = 0.001) and had lower Expanded Disability Status Scale scores at baselin …
Author Correction: Ballistic Majorana nanowire devices.
Gül Ö, Zhang H, Bommer JDS, de Moor MWA, Car D, Plissard SR, Bakkers EPAM, Geresdi A, Watanabe K, Taniguchi T, Kouwenhoven LP. Gül Ö, et al. Among authors: de moor mwa. Nat Nanotechnol. 2024 Mar;19(3):415-417. doi: 10.1038/s41565-024-01602-8. Nat Nanotechnol. 2024. PMID: 38467868 No abstract available.
First-trimester intrauterine hematoma and pregnancy complications.
Al-Memar M, Vaulet T, Fourie H, Bobdiwala S, Farren J, Saso S, Bracewell-Milnes T, Moor B, Sur S, Stalder C, Bennett P, Timmerman D, Bourne T. Al-Memar M, et al. Ultrasound Obstet Gynecol. 2020 Apr;55(4):536-545. doi: 10.1002/uog.20861. Ultrasound Obstet Gynecol. 2020. PMID: 31483898 Free article.
Diagnosis of a retroplacental IUH was associated with an increased risk of overall antenatal complications (P = 0.04). CONCLUSIONS: Our findings demonstrate that there is no association between the presence of IUH in the first trimester and first-trimester miscarriage. ...
Diagnosis of a retroplacental IUH was associated with an increased risk of overall antenatal complications (P = 0.04). CONCLUSIONS: O …
Retraction Note: Epitaxy of advanced nanowire quantum devices.
Gazibegovic S, Car D, Zhang H, Balk SC, Logan JA, de Moor MWA, Cassidy MC, Schmits R, Xu D, Wang G, Krogstrup P, Op Het Veld RLM, Zuo K, Vos Y, Shen J, Bouman D, Shojaei B, Pennachio D, Lee JS, van Veldhoven PJ, Koelling S, Verheijen MA, Kouwenhoven LP, Palmstrøm CJ, Bakkers EPAM. Gazibegovic S, et al. Among authors: de moor mwa. Nature. 2022 Apr;604(7907):786. doi: 10.1038/s41586-022-04704-2. Nature. 2022. PMID: 35440766 No abstract available.
Benefits of early treatment with natalizumab: a real-world study.
Ontaneda D, Mowry EM, Newsome SD, Naismith RT, Nicholas J, Fisher E, de Moor C, Bohn J, Ho PR, Sandrock A, Rudick R, Williams JR. Ontaneda D, et al. Among authors: de moor c. Mult Scler Relat Disord. 2022 Dec;68:104216. doi: 10.1016/j.msard.2022.104216. Epub 2022 Oct 3. Mult Scler Relat Disord. 2022. PMID: 36288658 Free article.

A significant association between later natalizumab use and worse outcomes was demonstrated for walking speed (p < 0.001), processing speed (p < 0.001), manual dexterity (p < 0.001), brain atrophy (p = 0.001), and T2 lesion volume (p =

…

A significant association between later natalizumab use and worse outcomes was demonstrated for walking speed (p < 0.001), process

…
The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review.
Karim ME, Pellegrini F, Platt RW, Simoneau G, Rouette J, de Moor C. Karim ME, et al. Among authors: de moor c. Mult Scler. 2022 Aug;28(9):1317-1323. doi: 10.1177/1352458520972557. Epub 2020 Nov 12. Mult Scler. 2022. PMID: 33179573 Free PMC article. Review.
Most studies using matching or weighting reported checking post-PS covariate imbalance (91%), although about 45% of these studies relied on p values from various statistical tests. Only 25% of studies using matching reported calculating robust standard errors for the PS an …
Most studies using matching or weighting reported checking post-PS covariate imbalance (91%), although about 45% of these studies relied on …
Ballistic Majorana nanowire devices.
Gül Ö, Zhang H, Bommer JDS, de Moor MWA, Car D, Plissard SR, Bakkers EPAM, Geresdi A, Watanabe K, Taniguchi T, Kouwenhoven LP. Gül Ö, et al. Among authors: de moor mwa. Nat Nanotechnol. 2018 Mar;13(3):192-197. doi: 10.1038/s41565-017-0032-8. Epub 2018 Jan 15. Nat Nanotechnol. 2018. PMID: 29335565
268 results